Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicifadine Long-Term Safety in Chronic Low Back Pain
NCT00281645Phase 3Completed
- Sponsor
- DOV Pharmaceutical, Inc.
- Start
- Dec 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bicifadine in chronic low back pain (CLBP), sponsored by DOV Pharmaceutical, Inc.. Started Dec 2004; status: completed.
02
Drugs
bicifadine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00281645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281645.